Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

BACKGROUND: The inflammatory response occurring in acute myocardial infarction (AMI) has been proposed as a potential pharmacological target. Sodium-glucose co-transporter 2 inhibitors (SGLT2-I) currently receive intense clinical interest in patients with and without diabetes mellitus (DM) for their...

Descripción completa

Detalles Bibliográficos
Autores principales: Paolisso, Pasquale, Bergamaschi, Luca, Santulli, Gaetano, Gallinoro, Emanuele, Cesaro, Arturo, Gragnano, Felice, Sardu, Celestino, Mileva, Niya, Foà, Alberto, Armillotta, Matteo, Sansonetti, Angelo, Amicone, Sara, Impellizzeri, Andrea, Casella, Gianni, Mauro, Ciro, Vassilev, Dobrin, Marfella, Raffaele, Calabrò, Paolo, Barbato, Emanuele, Pizzi, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107763/
https://www.ncbi.nlm.nih.gov/pubmed/35570280
http://dx.doi.org/10.1186/s12933-022-01506-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107763/
https://www.ncbi.nlm.nih.gov/pubmed/35570280
http://dx.doi.org/10.1186/s12933-022-01506-8

Ejemplares similares